Filing Details
- Accession Number:
- 0001079973-25-000265
- Form Type:
- 13G Filing
- Publication Date:
- 2025-02-13 19:00:00
- Filed By:
- L1 Capital Global Opportunities Master Fund, Ltd.
- Company:
- Sunshine Biopharma Inc. (OTCMKTS:SBFM)
- Filing Date:
- 2025-02-14
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
Name | Beneficially Owned Number of Shares | Beneficially Owned Number of Aggregate Shares | Percent of Class |
---|---|---|---|
L1 Capital Global Opportunities Master Fund, Ltd. | 0 | 142,244 | 4.99% |
Filing
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G
|
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
(Amendment No. 1)
|
Sunshine Biopharma Inc. (Name of Issuer) |
Common Stock, $0.001 par value (Title of Class of Securities) |
867781403 (CUSIP Number) |
12/31/2024 (Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
![]() |
![]() |
![]() |
SCHEDULE 13G
|
CUSIP No. | 867781403 |
1 | Names of Reporting Persons
L1 Capital Global Opportunities Master Fund, Ltd. | ||||||||
2 | Check the appropriate box if a member of a Group (see instructions)
![]() ![]() | ||||||||
3 | Sec Use Only | ||||||||
4 | Citizenship or Place of Organization
CAYMAN ISLANDS
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
9 | Aggregate Amount Beneficially Owned by Each Reporting Person
142,244.00 | ||||||||
10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
![]() | ||||||||
11 | Percent of class represented by amount in row (9)
4.99 % | ||||||||
12 | Type of Reporting Person (See Instructions)
FI |
SCHEDULE 13G
|
Item 1. | ||
(a) | Name of issuer:
Sunshine Biopharma Inc. | |
(b) | Address of issuer's principal executive offices:
333 Las Olas Wy, CU4 Suite 433, Fort Lauderdale, FL 33301 | |
Item 2. | ||
(a) | Name of person filing:
L1 Capital Global Opportunities Master Fund, Ltd. | |
(b) | Address or principal business office or, if none, residence:
161A Shedden Road, 1 Artillery Court, PO Box 10085
Grand Cayman, Cayman Islands KY1-1001 | |
(c) | Citizenship:
Cayman Islands | |
(d) | Title of class of securities:
Common Stock, $0.001 par value | |
(e) | CUSIP No.:
867781403 | |
Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
(a) | ![]() | |
(b) | ![]() | |
(c) | ![]() | |
(d) | ![]() | |
(e) | ![]() | |
(f) | ![]() | |
(g) | ![]() | |
(h) | ![]() | |
(i) | ![]() | |
(j) | ![]() please specify the type of institution: | |
(k) | ![]() | |
Item 4. | Ownership | |
(a) | Amount beneficially owned:
142,244
This amendment refers to a Schedule 13G filed with the Securities and Exchange Commission on February 23, 2024, covering 5,285,714 shares of Common Stock purchased and underlying Warrants purchased on February 13, 2024. The amounts in Row (5), (7) and (9) include Common Stock underlying 142,244 Series B Warrants, which are subject to a 4.99% beneficial ownership limitation. Does not include 2,296,780 Series B Warrants to purchase Common Shares of the Issuer, which is subject to a 4.99% beneficial ownership limitation. The percentage set forth on Row (11) of the cover page for the reporting person is based on 2,708,341 shares of Common Shares outstanding as of January 3, 2025, based on the Issuer's Registration Statement on Form S-3 filed with the Securities and Exchange Commission on January 6, 2025.
David Feldman and Joel Arber are the Directors of L1 Capital Global Opportunities Master Fund, Ltd. As such, L1 Capital Global Opportunities Master Fund, Ltd., Mr. Feldman, and Mr. Arber may be deemed to beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the issuer's securities described herein. To the extent Mr. Feldman and Mr. Arber are deemed to beneficially own such securities, Mr. Feldman and Mr. Arber disclaim beneficial ownership of these securities for all other purposes. | |
(b) | Percent of class:
4.99 %
| |
(c) | Number of shares as to which the person has:
| |
(i) Sole power to vote or to direct the vote:
142,244 | ||
(ii) Shared power to vote or to direct the vote:
0 | ||
(iii) Sole power to dispose or to direct the disposition of:
142,244 | ||
(iv) Shared power to dispose or to direct the disposition of:
0 | ||
Item 5. | Ownership of 5 Percent or Less of a Class. | |
![]() | ||
Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
Not Applicable
| ||
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
Not Applicable
| ||
Item 8. | Identification and Classification of Members of the Group. | |
Not Applicable
| ||
Item 9. | Notice of Dissolution of Group. | |
Not Applicable
|
Item 10. | Certifications: |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. |
SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|